Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ménard

Showing results (61-70 of 222) with videos related to

Pageof 23
Sort By:
L'Union Medicale Du Canada|February 1, 1972
[In favor of a therapeutic climate in a clinic for young drug users]B S Ménard, Y Lamontagne, S Thibodeau, et al.
Cancer Research|May 1, 1996
Oral administration of anti-doxorubicin monoclonal antibody prevents chemotherapy-induced gastrointestinal toxicity in miceD Morelli, S Ménard, M I Colnaghi, et al.
Microbial Pathogenesis|September 1, 1996
Detection and localization of the EaeA protein of attaching and effacing Escherichia coli O45 from pigs using a monoclonal antibodyC Zhu, S Ménard, J D Dubreuil, et al.
Breast Cancer Research and Treatment|January 5, 2002
The early relapse of premenopausal patients after surgery for node-positive breast carcinomaE Tagliabue, R Agresti, C Ghirelli, et al.
Cancer Research|December 15, 1993
Antibody response against the c-erbB-2 oncoprotein in breast carcinoma patientsS M Pupa, S Ménard, S Andreola, et al.
Human Pathology|May 1, 1995
Expression of the monomeric 67-kd laminin-binding protein in human lymphomas as defined by MLuC5 monoclonal antibody and paraffin section immunohistochemistryA Carbone, A Gloghini, A Colombatti, et al.
Oncology|November 6, 2001
HER2 as a prognostic factor in breast cancerS Ménard, S Fortis, F Castiglioni, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 27, 1999
Correlation between tumor vascularity, vascular endothelial growth factor production by tumor cells, serum vascular endothelial growth factor levels, and serum angiogenic activity in patients with breast carcinomaA Balsari, J A Maier, M I Colnaghi, et al.
British Journal of Cancer|April 3, 2003
Role of hormonal risk factors in HER2-positive breast carcinomasA Balsari, P Casalini, R Bufalino, et al.
Lancet (London, England)|July 22, 1998
Proliferation of breast carcinoma during menstrual phasesS Ménard, P Casalini, R Agresti, et al.
Pageof 23

Showing results (61-70 of 222) with videos related to

Sort By:
Pageof 23
L'Union Medicale Du Canada|February 1, 1972
[In favor of a therapeutic climate in a clinic for young drug users]B S Ménard, Y Lamontagne, S Thibodeau, et al.
Cancer Research|May 1, 1996
Oral administration of anti-doxorubicin monoclonal antibody prevents chemotherapy-induced gastrointestinal toxicity in miceD Morelli, S Ménard, M I Colnaghi, et al.
Microbial Pathogenesis|September 1, 1996
Detection and localization of the EaeA protein of attaching and effacing Escherichia coli O45 from pigs using a monoclonal antibodyC Zhu, S Ménard, J D Dubreuil, et al.
Breast Cancer Research and Treatment|January 5, 2002
The early relapse of premenopausal patients after surgery for node-positive breast carcinomaE Tagliabue, R Agresti, C Ghirelli, et al.
Cancer Research|December 15, 1993
Antibody response against the c-erbB-2 oncoprotein in breast carcinoma patientsS M Pupa, S Ménard, S Andreola, et al.
Human Pathology|May 1, 1995
Expression of the monomeric 67-kd laminin-binding protein in human lymphomas as defined by MLuC5 monoclonal antibody and paraffin section immunohistochemistryA Carbone, A Gloghini, A Colombatti, et al.
Oncology|November 6, 2001
HER2 as a prognostic factor in breast cancerS Ménard, S Fortis, F Castiglioni, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 27, 1999
Correlation between tumor vascularity, vascular endothelial growth factor production by tumor cells, serum vascular endothelial growth factor levels, and serum angiogenic activity in patients with breast carcinomaA Balsari, J A Maier, M I Colnaghi, et al.
British Journal of Cancer|April 3, 2003
Role of hormonal risk factors in HER2-positive breast carcinomasA Balsari, P Casalini, R Bufalino, et al.
Lancet (London, England)|July 22, 1998
Proliferation of breast carcinoma during menstrual phasesS Ménard, P Casalini, R Agresti, et al.
Pageof 23